Methods for assessing antibodies to neurodegenerative disease-associated antigens
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 20, 2006
app pub date -
Oct 26, 2005
filing date -
Oct 26, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention provides methods for assessing immunoglobulins directed to neurodegenerative disease-associated antigens. Methods of the instant invention involve specific, sensitive and precise identification of Ig classes of antibodies present in a test sample that are capable of binding an immobilized neurodegenerative disease-associated antigen. The enhanced assessment of antibodies directed to specific neurodegenerative disease-associated antigens that is enabled by the invention improves both monitoring of neurodegenerative disease treatment and prediction of neurodegenerative disease progression.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully